NELFE_HUMAN - dbPTM
NELFE_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID NELFE_HUMAN
UniProt AC P18615
Protein Name Negative elongation factor E
Gene Name NELFE
Organism Homo sapiens (Human).
Sequence Length 380
Subcellular Localization Nucleus.
Protein Description Essential component of the NELF complex, a complex that negatively regulates the elongation of transcription by RNA polymerase II. The NELF complex, which acts via an association with the DSIF complex and causes transcriptional pausing, is counteracted by the P-TEFb kinase complex. The NELF complex is involved in HIV-1 latency possibly involving recruitment of PCF11 to paused RNA polymerase II. Provides the strongest RNA binding activity of the NELF complex and may initially recruit the NELF complex to RNA. Binds to the HIV-1 TAR RNA which is located in the long terminal repeat (LTR) of HIV-1..
Protein Sequence MLVIPPGLSEEEEALQKKFNKLKKKKKALLALKKQSSSSTTSQGGVKRSLSEQPVMDTATATEQAKQLVKSGAISAIKAETKNSGFKRSRTLEGKLKDPEKGPVPTFQPFQRSISADDDLQESSRRPQRKSLYESFVSSSDRLRELGPDGEEAEGPGAGDGPPRSFDWGYEERSGAHSSASPPRSRSRDRSHERNRDRDRDRERDRDRDRDRDRERDRDRDRDRDRDRERDRDRERDRDRDREGPFRRSDSFPERRAPRKGNTLYVYGEDMTPTLLRGAFSPFGNIIDLSMDPPRNCAFVTYEKMESADQAVAELNGTQVESVQLKVNIARKQPMLDAATGKSVWGSLAVQNSPKGCHRDKRTQIVYSDDVYKENLVDGF
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
9PhosphorylationLVIPPGLSEEEEALQ
CCCCCCCCHHHHHHH
49.2128122231
332-HydroxyisobutyrylationKKALLALKKQSSSST
HHHHHHHHHHCCCCC
43.06-
33AcetylationKKALLALKKQSSSST
HHHHHHHHHHCCCCC
43.0625953088
36PhosphorylationLLALKKQSSSSTTSQ
HHHHHHHCCCCCCCC
40.8628348404
37PhosphorylationLALKKQSSSSTTSQG
HHHHHHCCCCCCCCC
26.3022496350
38PhosphorylationALKKQSSSSTTSQGG
HHHHHCCCCCCCCCC
36.6328348404
39PhosphorylationLKKQSSSSTTSQGGV
HHHHCCCCCCCCCCC
37.3428348404
40PhosphorylationKKQSSSSTTSQGGVK
HHHCCCCCCCCCCCC
32.2028348404
41PhosphorylationKQSSSSTTSQGGVKR
HHCCCCCCCCCCCCC
22.4724114839
42PhosphorylationQSSSSTTSQGGVKRS
HCCCCCCCCCCCCCC
27.2424114839
47SumoylationTTSQGGVKRSLSEQP
CCCCCCCCCCCCCCC
39.27-
47SumoylationTTSQGGVKRSLSEQP
CCCCCCCCCCCCCCC
39.27-
49PhosphorylationSQGGVKRSLSEQPVM
CCCCCCCCCCCCCCC
30.4529255136
51PhosphorylationGGVKRSLSEQPVMDT
CCCCCCCCCCCCCCC
35.1229255136
56SulfoxidationSLSEQPVMDTATATE
CCCCCCCCCCHHHHH
4.8921406390
58PhosphorylationSEQPVMDTATATEQA
CCCCCCCCHHHHHHH
14.0730266825
60PhosphorylationQPVMDTATATEQAKQ
CCCCCCHHHHHHHHH
35.8830266825
62PhosphorylationVMDTATATEQAKQLV
CCCCHHHHHHHHHHH
25.0323927012
71PhosphorylationQAKQLVKSGAISAIK
HHHHHHHHCCHHHHE
26.4425159151
75PhosphorylationLVKSGAISAIKAETK
HHHHCCHHHHEEHHC
24.3325159151
78SumoylationSGAISAIKAETKNSG
HCCHHHHEEHHCCCC
39.63-
78SumoylationSGAISAIKAETKNSG
HCCHHHHEEHHCCCC
39.6325114211
78AcetylationSGAISAIKAETKNSG
HCCHHHHEEHHCCCC
39.6325953088
82SumoylationSAIKAETKNSGFKRS
HHHEEHHCCCCCCCC
40.3928112733
84PhosphorylationIKAETKNSGFKRSRT
HEEHHCCCCCCCCEE
47.3521857030
89PhosphorylationKNSGFKRSRTLEGKL
CCCCCCCCEEECCCC
30.1522817900
91PhosphorylationSGFKRSRTLEGKLKD
CCCCCCEEECCCCCC
30.3329900121
95UbiquitinationRSRTLEGKLKDPEKG
CCEEECCCCCCCCCC
42.88-
97AcetylationRTLEGKLKDPEKGPV
EEECCCCCCCCCCCC
74.7925953088
101AcetylationGKLKDPEKGPVPTFQ
CCCCCCCCCCCCCCC
74.1125953088
106PhosphorylationPEKGPVPTFQPFQRS
CCCCCCCCCCCCCCC
34.8326074081
113PhosphorylationTFQPFQRSISADDDL
CCCCCCCCCCCCCCH
15.3122167270
115PhosphorylationQPFQRSISADDDLQE
CCCCCCCCCCCCHHH
27.2219664994
123PhosphorylationADDDLQESSRRPQRK
CCCCHHHHCCCHHHH
19.0425159151
124PhosphorylationDDDLQESSRRPQRKS
CCCHHHHCCCHHHHH
31.4023927012
130UbiquitinationSSRRPQRKSLYESFV
HCCCHHHHHHHHHHH
39.3021890473
130UbiquitinationSSRRPQRKSLYESFV
HCCCHHHHHHHHHHH
39.3021890473
131PhosphorylationSRRPQRKSLYESFVS
CCCHHHHHHHHHHHC
38.0725159151
133PhosphorylationRPQRKSLYESFVSSS
CHHHHHHHHHHHCCH
19.3322167270
135PhosphorylationQRKSLYESFVSSSDR
HHHHHHHHHHCCHHH
19.8623927012
138PhosphorylationSLYESFVSSSDRLRE
HHHHHHHCCHHHHHH
23.3223927012
139PhosphorylationLYESFVSSSDRLREL
HHHHHHCCHHHHHHH
30.8423927012
140PhosphorylationYESFVSSSDRLRELG
HHHHHCCHHHHHHHC
21.1723927012
142MethylationSFVSSSDRLRELGPD
HHHCCHHHHHHHCCC
37.28115490999
165PhosphorylationAGDGPPRSFDWGYEE
CCCCCCCCCCCCCCC
33.0722115753
170PhosphorylationPRSFDWGYEERSGAH
CCCCCCCCCCCCCCC
15.4628796482
174PhosphorylationDWGYEERSGAHSSAS
CCCCCCCCCCCCCCC
43.5430266825
178PhosphorylationEERSGAHSSASPPRS
CCCCCCCCCCCCCCC
27.3730266825
179PhosphorylationERSGAHSSASPPRSR
CCCCCCCCCCCCCCC
23.9323927012
181PhosphorylationSGAHSSASPPRSRSR
CCCCCCCCCCCCCCC
37.0723927012
185PhosphorylationSSASPPRSRSRDRSH
CCCCCCCCCCCCCCH
40.1426055452
187PhosphorylationASPPRSRSRDRSHER
CCCCCCCCCCCCHHH
39.5228464451
191PhosphorylationRSRSRDRSHERNRDR
CCCCCCCCHHHHHHH
33.7120068231
249PhosphorylationREGPFRRSDSFPERR
CCCCCCCCCCCCCCC
33.0930266825
251PhosphorylationGPFRRSDSFPERRAP
CCCCCCCCCCCCCCC
43.9025159151
263PhosphorylationRAPRKGNTLYVYGED
CCCCCCCEEEEECCC
28.3029978859
265PhosphorylationPRKGNTLYVYGEDMT
CCCCCEEEEECCCCC
6.9218669648
267PhosphorylationKGNTLYVYGEDMTPT
CCCEEEEECCCCCHH
10.9718669648
272PhosphorylationYVYGEDMTPTLLRGA
EEECCCCCHHHHCCC
25.9925159151
274PhosphorylationYGEDMTPTLLRGAFS
ECCCCCHHHHCCCCC
29.2921082442
281PhosphorylationTLLRGAFSPFGNIID
HHHCCCCCCCCCEEE
20.8425159151
332UbiquitinationLKVNIARKQPMLDAA
EEEEHHHHCCCCHHH
50.13-
340PhosphorylationQPMLDAATGKSVWGS
CCCCHHHCCCCHHHH
47.0320044836
343PhosphorylationLDAATGKSVWGSLAV
CHHHCCCCHHHHHHH
25.1726074081
347PhosphorylationTGKSVWGSLAVQNSP
CCCCHHHHHHHCCCC
9.4620044836
353PhosphorylationGSLAVQNSPKGCHRD
HHHHHCCCCCCCCCC
15.7619664994
363PhosphorylationGCHRDKRTQIVYSDD
CCCCCCCCEEEECCC
28.5222210691
367PhosphorylationDKRTQIVYSDDVYKE
CCCCEEEECCCHHHH
14.1725159151
368PhosphorylationKRTQIVYSDDVYKEN
CCCEEEECCCHHHHH
19.2128387310
372PhosphorylationIVYSDDVYKENLVDG
EEECCCHHHHHCCCC
21.4122210691

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
51SPhosphorylationKinaseMAPKAPK2P49137
PSP
115SPhosphorylationKinaseMAPKAPK2P49137
PSP
131SPhosphorylationKinaseAURKBQ96GD4
GPS
251SPhosphorylationKinaseMAPKAPK2P49137
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of NELFE_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of NELFE_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
NELFB_HUMANNELFBphysical
14667819
NCOR1_HUMANNCOR1physical
14667819
CATIN_HUMANCACTINphysical
14667819
NELFA_HUMANNELFAphysical
12612062
NELFB_HUMANNELFBphysical
12612062
NELFD_HUMANNELFCDphysical
12612062
RPB1_HUMANPOLR2Aphysical
12612062
VAMP3_HUMANVAMP3physical
16169070
NELFB_HUMANNELFBphysical
20305087
SF3B1_HUMANSF3B1physical
20305087
NELFD_HUMANNELFCDphysical
20305087
TM141_HUMANTMEM141physical
20305087
NELFA_HUMANNELFAphysical
20305087
MTUS2_HUMANMTUS2physical
25416956
CCD57_HUMANCCDC57physical
25416956
NELFA_HUMANNELFAphysical
26186194
NELFD_HUMANNELFCDphysical
26186194
NELFB_HUMANNELFBphysical
26186194
SMBP2_HUMANIGHMBP2physical
26186194
RRP44_HUMANDIS3physical
26186194
NELFA_HUMANNELFAphysical
26496610
NELFB_HUMANNELFBphysical
26496610
RSRC1_HUMANRSRC1physical
26496610
NELFD_HUMANNELFCDphysical
26496610
NELFA_HUMANNELFAphysical
28514442
NELFD_HUMANNELFCDphysical
28514442
NELFB_HUMANNELFBphysical
28514442
SMBP2_HUMANIGHMBP2physical
28514442
RRP44_HUMANDIS3physical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of NELFE_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-51; SER-131 AND SER-353,AND MASS SPECTROMETRY.
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-115, AND MASSSPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-115 AND SER-353, ANDMASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-113; SER-131; SER-251;TYR-265; TYR-267; THR-272; THR-274; SER-281 AND SER-353, AND MASSSPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-115, AND MASSSPECTROMETRY.
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis.";
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III;
J. Proteome Res. 7:1346-1351(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-131 AND SER-281, ANDMASS SPECTROMETRY.
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column.";
Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.;
Anal. Sci. 24:161-166(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-51, AND MASSSPECTROMETRY.
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis.";
Wang B., Malik R., Nigg E.A., Korner R.;
Anal. Chem. 80:9526-9533(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-115, AND MASSSPECTROMETRY.
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra.";
Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
J. Proteome Res. 6:4150-4162(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-181, AND MASSSPECTROMETRY.
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization.";
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
Nat. Biotechnol. 24:1285-1292(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-115 AND SER-353, ANDMASS SPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-115 AND SER-191, ANDMASS SPECTROMETRY.
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-115, AND MASSSPECTROMETRY.

TOP